Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma

February 22, 2018

Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma

Published on 02/21/2018

previous post: Glucagon-like peptide-1 receptor agonist use and renal impairment: A retrospective analysis of an electronic health records database in the U.S. population
next post: Gene expression screening identifies <em>CDCA5</em> as a potential therapeutic target in acral melanoma